thiamphenicol has been researched along with losartan potassium in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Adamson, JW; Yunis, AA | 1 |
| Kardaun, S; Nijhof, W; Wierenga, PK | 1 |
| Dontje, B; Dresz, J; Goris, H; Loeffler, M; Nijhof, W | 1 |
| Geiger, JN; Johnson, MM; Miller, CP; Pircher, TJ; Wojchowski, DM; Zhang, D | 1 |
| Chang, KH; Stevenson, MM; Tam, M; Thawani, N | 1 |
6 other study(ies) available for thiamphenicol and losartan potassium
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Differential in vitro sensitivity of marrow erythroid and granulocytic colony forming cells to chloramphenicol.
Topics: Animals; Cell Differentiation; Chloramphenicol; Clone Cells; Dose-Response Relationship, Drug; Erythroblasts; Erythropoietin; Granulocytes; Hematopoietic Stem Cells; Humans; In Vitro Techniques; Mice; Thiamphenicol | 1977 |
The effect of thiamphenicol on the production of immature red blood cells under anaemic conditions.
Topics: Anemia; Animals; Anti-Bacterial Agents; Bone Marrow; Bone Marrow Cells; Cell Differentiation; Cell Line; Erythrocyte Count; Erythropoiesis; Erythropoietin; Hemoglobins; Polyribosomes; Rabbits; Reticulocytes; Ribosomes; Thiamphenicol | 1977 |
Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Erythropoiesis; Erythropoietin; Female; Granulocytes; Hematocrit; Hematopoiesis; Mice; Mice, Inbred C57BL; Recombinant Proteins; Reticulocytes; Spleen; Thiamphenicol | 1993 |
An optimized system for studies of EPO-dependent murine pro-erythroblast development.
Topics: Animals; Biomarkers; Cattle; Cell Differentiation; Cell Separation; Culture Media; Culture Media, Serum-Free; DNA-Binding Proteins; Dyrk Kinases; Erythroid Precursor Cells; Erythroid-Specific DNA-Binding Factors; Erythropoiesis; Erythropoietin; Fetal Blood; Flow Cytometry; Globins; Hyperplasia; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Receptor Protein-Tyrosine Kinases; Receptors, Cell Surface; Receptors, Erythropoietin; Spleen; Thiamphenicol; Transcription Factors; Transcription, Genetic | 2001 |
Interferon-gamma mediates suppression of erythropoiesis but not reduced red cell survival following CpG-ODN administration in vivo.
Topics: Anemia; Animals; Cell Survival; Erythrocytes; Erythropoiesis; Erythropoietin; Female; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Interferon-gamma; Mice; Mice, Inbred C57BL; Oligodeoxyribonucleotides; Recombinant Proteins; Reticulocytosis; Spleen; Thiamphenicol | 2006 |